Cell Division is an open access, peer-reviewed journal, which publishes articles in areas including, but not limited to, molecular aspects of cell cycle control and cancer, cell growth, proliferation, survival, differentiation, signalling, gene transcription, protein synthesis, genome integrity, chromosome stability, centrosome duplication, DNA damage and DNA repair.
Featured Article: Detection of early relapse in multiple myeloma patients
Multiple myeloma remains a hard to treat disease, as almost all patients relapse. It is currently not possible to predict when relapse will occur, but studies suggest that microRNAs could be good markers of relapse.
Public domain image from https://commons.wikimedia.org/wiki/File:Multiple_myeloma_(1)_MG_stain.jpg
Articles
-
-
LncPRESS1 promotes the progression and cisplatin resistance of breast cancer through upregulation of ENO1 and activation of glycolysis
-
FGF4 drives tumor progression in triple-negative breast cancer via IL6/STAT3-mediated macrophage M2 polarization and immune suppression
-
SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression
-
TFAP2A upregulates FAM83A to suppress ferroptosis and diminish cisplatin sensitivity in non-small cell lung cancer
Call for Papers: New Biomarkers of Solid and Hematological Malignancies
Cell Division is calling for submissions to our Collection on New Biomarkers of Solid and Hematological Malignancies. This Collection focuses on the latest discoveries of biomarkers in both solid and hematological malignancies, aiming to highlight their potential in improving cancer diagnosis, prognosis, and personalized therapy.
Read MoreAims and scope
Follow
Annual Journal Metrics
-
Citation Impact
Journal Impact Factor: 2.2 (2024)
5-year Journal Impact Factor: 2.3 (2024)
Source Normalized Impact per Paper (SNIP): 0.548 (2024)
SCImago Journal Rank (SJR): 0.768 (2024)Speed
Submission to first editorial decision (median days): 12
Submission to acceptance (median days): 128Usage 2024
Downloads: 179,933
Altmetric mentions: 38